{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', '17.5.', 'Amendment 05 Dated 25 March 2019', 'The primary reason for this amendment is to update the anticipated patient enrollment numbers', 'and related statistical considerations, update requirements on drug storage and security, to', 'update/clarify patient inclusion criteria and withdrawal criteria, to update administrative details', 'with regards to clinical study personnel contact information and vendor selection, and to provide', 'additional guidance on dose suspension.', 'This amendment is considered to be substantial (ie, requires approval by Competent Authority,', \"IEC, and/or IRB) by the sponsor's Authorized Representative. Other nonsubstantial changes\", 'have been made to the protocol (and protocol synopsis, as appropriate). These changes are', 'unlikely to affect the safety or rights (physical or mental integrity) of the patients in this clinical', 'study or the scientific value of the clinical study.', '195']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'Protocol Amendment 04 text with changes shown', 'New wording', 'Reason/Justification for change', 'Global', 'INC Research Syneos Health', 'Syneos Health', 'Administrative update to account', 'for vendor name change', 'Title Page', '601 Gateway Boulevard', '101 Main Street, 12th Floor', 'Address update', 'Suite 1270', 'Cambridge, Massachusetts 02142', 'South San Francisco, California 94080', '101 Main Street, 12th Floor', 'Cambridge, Massachusetts 02142', 'This clinical study will be conducted in accordance', 'This clinical study will be conducted in accordance', \"Updates included per Teva's current\", 'with current Good Clinical Practice (GCP) as directed', 'with current Good Clinical Practice (GCP) as directed', 'Confidentiality Statement template', 'by the provisions of the International', 'by the provisions of the International Council for', 'text', 'ConferenceCounc for Harmonisation (ICH); United', 'Harmonisation (ICH); United States (US) Code of', 'States (US) Code of Federal Regulations (CFR), and', 'Federal Regulations (CFR), and European Union (EU)', 'European Union (EU) Directives and Regulations (as', 'Directives and Regulations (as applicable in the region', 'applicable in the region of the study); national country', 'of the study); national country legislation; and the', \"regulationslegislation; and the sponsor's Standard\", \"sponsor's Standard Operating Procedures (SOPs).\", 'Operating Procedures (SOPs).', 'This document contains confidential and proprietary', 'This document contains confidential and proprietary', 'information (including confidential commercial', 'information (including confidential commercial', 'information pursuant to 21CFR\u00a720.61 and is a', 'information pursuant to 21CFR\u00a720.61) and is a', 'confidential communication of Teva Branded', 'confidential communication of Teva Branded', 'Pharmaceutical Products R&D and/or its affiliates and', 'Pharmaceutical Products R&D and/or its affiliates and', 'Nuvelution TS Pharma, INC.', 'Nuvelution TS Pharma, INC.', '\u00a9 2019 Teva Branded Pharmaceutical Products R&D,', '\u00a9 20172019 Teva Branded Pharmaceutical Products', 'Inc. and Nuvelution TS Pharma, INC. All rights', 'R&D, Inc. and Nuvelution TS Pharma, INC. All rights', 'reserved.', 'reserved.', 'LABORATORY AND OTHER DEPARTMENTS AND INSTITUTIONS', 'Contract Research Organization; Safety and', 'Contract Research Organization; Safety and', 'Administrative change', 'Efficacy Data Analysis', 'Efficacy Data Analysis', 'INC Research, LLC, a Syncos health group company', 'Syneos Health, LLC', '(Syneos Health, LLC)', '1030 Sync Street', '3201 Beechleaf Court', 'Morrisville, NC 27560', '196']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'Protocol Amendment 04 text with changes shown', 'New wording', 'Reason/Justification for change', 'Suite 600', 'USA', 'Raleigh, NC 276041 1547', '1030 Sync Street', 'Morrisville, NC 27560', 'USA', 'CLINICAL STUDY PERSONNEL CONTACT INFORMATION', 'Legal Representative of the Sponsor in the EU', 'Legal Representative of the Sponsor in the EU', \"Update to the sponsor's legal\", 'Syneos Health Netherlands B.V.', 'Syneos Health Netherlands B.V.', 'representative in the EU.', 'Additional administrative changes', 'For medical issues, contact the physician listed', 'For medical issues, contact the physician listed', 'have been carried out.', 'below:', 'below:', 'For protocol issues, contact the study leaders', 'For protocol issues, contact the study leaders', 'listed below:', 'listed below:', '197']\n\n###\n\n", "completion": "END"}